By Dean Seal
Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official Deb Autor to its board.
The stock was up 8.8% at $21.02 in Monday trading. Shares have doubled since the start of the year.
The telehealth company said Autor, a former deputy commissioner at the FDA, has joined the board as a director.
Hims & Hers also said it has also hired Janet Stevens, the former chief quality officer of Hillrom, as its global head of quality and safety.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
November 18, 2024 13:52 ET (18:52 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.